Oncology Research Reports & Consulting

US & EU Melanoma Therapeutics market reached US$ 3.89 billion in 2024 and is expected to grow to US$ 8.99 billion by 2033 at a CAGR 9.8% (2025-2033).

Head and Neck Cancer Pipeline Insights

Global Esophageal Cancer Treatment Market is Segmented by Cancer Type (Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, Targeted Drug Therapy, Immunotherapy, Combination Therapy and Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic and Research Institutes and Others), and Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), with a Global Forecast from 2026 to 2035

According to DMI Analysis, Non-Small Cell Lung Cancer Therapeutics Market reached US$ 21.33 billion in 2024 and is expected to reach US$ 64.92 billion by 2033

Ovarian Cancer Drugs Market analysis with size, CAGR, key segments, regional growth drivers, and competitive landscape insights through forecast periods.

The global CAR-T Cell Therapy for Pediatric Cancers market was valued at US$ 2.24 billion in 2025 and is projected to reach US$ 24.03 billion by 2035, growing at a CAGR of 26.80% during the forecast period.

Global Epithelioid Sarcoma Treatment Market reached US$ 1.58 billion in 2025, growing with a CAGR of 9.1% during the forecast period 2026-2033.

Synovial Sarcoma Treatment Market is expected to reach a CAGR of YY% By 2031: DataM Intelligence

Targeted Therapy Market reached US$ 88.28 billion in 2025 and is expected to reach US$ 147.16 billion by 2033, growing at a CAGR of 7.2%

Pediatric Oncology Drugs Market analysis with size to 2033, drivers, drug classes, regional insights and key industry players.